About Bruce

A successful pharmaceutical executive with nearly 35 years of industry experience, Bruce Eaton serves as the president and chief executive officer of i2 Pharmaceuticals, Inc. In his leadership role with i2 Pharmaceuticals, he looks to expand the company‚Äôs intellectual property holdings, which include a broad range of early and late stage pharmaceutical assets. Through a… Continue Reading

Spotlight – MD Anderson Partners with Pfizer for Cancer Research

Spotlight – MD Anderson Partners with Pfizer for Cancer Research

As the field of immuno-oncology continues to grow, many organizations are launching interesting collaborations to speed discovery and trial periods. Recently, the University of Texas MD Anderson Cancer Center announced a strategic partnership with Pfizer to examine new combinations of immunotherapies with other therapies for blood cancers and solid tumors. This collaboration will involve a… Continue Reading

Spotlight – Roche Unveils an Important Blood Test

Spotlight – Roche Unveils an Important Blood Test

One of the most pressing issues in immuno-oncology is predicting which treatments will be most effective for which patients. While some individuals respond in dramatic ways to current immunotherapies, others show little, if any, improvement after receiving the treatment. Many companies have tried to identify genes and biomarkers that could help them figure out how… Continue Reading

FDA OKs Checkpoint Inhibitors for New Cancers – What You Need to Know

FDA OKs Checkpoint Inhibitors for New Cancers – What You Need to Know

Some of the most successful approaches to immuno-oncology have dealt with inhibition of the immune checkpoints expressed on cancer cells. These immune checkpoint inhibitor drugs include Keytruda and Opdivo, two of the most popular immunotherapies on the market. Keytruda has been approved as a treatment for metastatic melanoma and non-small cell lung cancer, as well… Continue Reading

Spotlight – The Struggle to Find a Cancer Vaccine Continues

Spotlight – The Struggle to Find a Cancer Vaccine Continues

With the exception of the HPV vaccine, which is a preventative rather than a therapeutic vaccine, most attempts at formulating a cancer vaccine have fallen flat. Most of the earliest cancer vaccines focused on bolstering the immune system to protect against cancer growth in the body. Sometimes, these vaccines did invoke a strong immune response,… Continue Reading